
Sign up to save your podcasts
Or


The combination of mifepristone and misoprostol is currently the most common abortion method in the US, and increased access to medication abortion through telemedicine is the only way for many patients in restrictive states to access care. Now states like Texas are attacking that access, despite decades of definitive safety data for mifepristone. In this episode, Bev and Jonas talk with Dr. Daniel Grossman, Professor of Obstetrics and Gynecology at UCSF and the director of ANSIRH (Advancing New Standards in Reproductive Health). He breaks down the history, safety, and current advances in science related to medication abortion and shares the facts you need to combat misinformation, especially about mifepristone.
Are you interested in making a tax-deductible donation to support the podcast? Click here!: https://www.gifts.duke.edu/dukehealth?designation=391001053
By Beverly Gray & Jonas Swartz4.5
185185 ratings
The combination of mifepristone and misoprostol is currently the most common abortion method in the US, and increased access to medication abortion through telemedicine is the only way for many patients in restrictive states to access care. Now states like Texas are attacking that access, despite decades of definitive safety data for mifepristone. In this episode, Bev and Jonas talk with Dr. Daniel Grossman, Professor of Obstetrics and Gynecology at UCSF and the director of ANSIRH (Advancing New Standards in Reproductive Health). He breaks down the history, safety, and current advances in science related to medication abortion and shares the facts you need to combat misinformation, especially about mifepristone.
Are you interested in making a tax-deductible donation to support the podcast? Click here!: https://www.gifts.duke.edu/dukehealth?designation=391001053

25,769 Listeners

14,621 Listeners

112,049 Listeners

56,516 Listeners

21,863 Listeners

15,000 Listeners

3,330 Listeners

7,253 Listeners

16,363 Listeners

329 Listeners

16,601 Listeners

4,133 Listeners

706 Listeners

561 Listeners